Under the auspices of the EU Accelerator Programme:
The Center for Early Detection and Interception of Blood Cancers is the first-of-its-kind clinic for patients with precursor conditions of hematologic malignancies. Building on Dana-Farber’s past and ongoing research efforts of precursor conditions, the clinic evaluates individuals diagnosed with these conditions or at high risk for disease development, and works with patients to manage their risk of disease progression. At the center, we strive to detect blood cancer precursor conditions and intervene early to prevent blood cancers from developing. Click here to find out more.





